Global Quinine Market Review 2015-2018 and Forecast 2019-2025HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Quinine Market Review 2015-2018 and Forecast 2019-2025PR NewswireJanuary 3, 2020ReblogShareTweetShareDUBLIN, Jan. 3, 2020 /PRNewswire/ -- The "Quinine Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025" report has been added to ResearchAndMarkets.com's offering.Research and Markets LogoMoreThe report covers forecast and analysis for the quinine market on a global and regional level. The study provides historic data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the quinine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the quinine market on a global level.As per the report, the global demand for quinine market was valued at approximately USD 804.98 million in 2018 and is expected to generate revenue of around USD 1,184.15 million by end of 2025, growing at a CAGR of around 5.68% between 2019 and 2025.Quinine is a drug used for the treatment of malaria and babesiosis. Quinine is used to treat malaria due to chloroquine-resistant Plasmodium falciparum when artesunate is not available. Although it is used for the syndrome of restless legs, it is not suggested for this purpose because of the danger of side effects. It can be used intravenously or by oral route. Resistance to quinine is observed in some parts of the globe. Quinine is also used in tonic water which imparts its bitter taste. Quinine was used after thoracoplasty to treat malaria and related febrile conditions, leg cramps triggered by vascular spasm, inner hemorrhoids, varicose veins, and pleural cavities.Based on mode of administration, the quinine market is segmented into oral administration, intravenous administration, intramuscular administration and others. Among the mode of administration segment, intramuscular segment is most commonly used mode of administration. Based on the application, the market is classified into antimalarial, antipyretic and others. The most dominant application segment is anti-malarial application in terms of revenue.End user segment of quinine market is further divided into hospitals, clinics, ambulatory surgery centers, and others. Hospitals application segment dominated the market in terms of revenue in 2018 owing to more inclination of patients towards the hospitals.Geographically, in 2017, the Middle East and Africa dominated the quinine industry and will continue to develop considerably over the forecast period. High production cinchona, an increasing incidence of malaria, and an increasing amount of fever cases will cascade the development of the sector over the forecast period. Asia Pacific is anticipated to closely follow the trend. Asia Pacific is anticipated to see the greatest development during the forecast period as a result of rising healthcare spending, rising disposable revenue leading to increased affordability, and increasing patient tendency towards quinine derivatives. High population base in India, improved patient knowledge of malaria, and increased fever causing diseases will further increase market growth.Some of the key players in quinine market include Alchem International, Van Wankum Ingredients, Arnold Suhr Qimpex, Vital Labs, Cosmos International, Chempro Pharma Private Limited, among others.Story continuesGlobal Quinine Market: Mode of Administration Segment AnalysisOral Administration Intravenous Administration Intramuscular Administration OthersGlobal Quinine Market: Application Segment AnalysisAntimalarial Antipyretic OthersGlobal Quinine Market: End-user Segment AnalysisHospitals Clinics Ambulatory Surgical Centers OthersFor more information about this report visit https://www.researchandmarkets.com/r/cjiwrcResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.Media Contact:Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716CisionMoreView original content:http://www.prnewswire.com/news-releases/global-quinine-market-review-2015-2018-and-forecast-2019-2025-300980906.htmlSOURCE Research and MarketsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiohaven drug wins U.S. FDA approval for use in relieving migraine headachesReutersRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance Video